Shares in AVO cancelled from trading on AIM

Shares in Advanced Oncotherapy (AVO) have been cancelled from trading on AIM as the proton beam therapy business continues to grapple with ongoing cash flow issues and a refinancing deal that has failed to materialise. The news comes just days after the company announced yet another delay to its proposed financing transaction with a new…

You must be a HM Subscriber to view this content.

Subscribe Now »